Genelux Corporation (GNLX)
(Delayed Data from NSDQ)
$2.75 USD
-0.06 (-2.14%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $2.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 11 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 11 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 24 | 14 | 15 | 0 | 0 |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Non-Operating Income | -4 | 0 | -1 | NA | NA |
Interest Expense | 0 | 1 | 1 | NA | NA |
Pretax Income | -28 | -4 | -16 | NA | NA |
Income Taxes | 0 | 1 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -28 | -5 | -16 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -28 | -5 | -16 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -23 | -2 | -14 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | NA | NA |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.43 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.14 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.16 | -0.57 | NA | NA | NA |
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.01 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.01 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.90 | 8.12 | 7.00 | 5.31 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.90 | -8.11 | -7.00 | -5.31 |
Non-Operating Income | NA | 0.32 | 0.27 | 0.24 | -0.04 |
Interest Expense | NA | 0.00 | 0.00 | 0.01 | 0.00 |
Pretax Income | NA | -6.58 | -7.85 | -6.77 | -5.35 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.58 | -7.85 | -6.77 | -5.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.58 | -7.85 | -6.77 | -5.35 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.69 | 26.85 | 27.33 | 26.21 |
Diluted EPS Before Non-Recurring Items | NA | -0.22 | -0.29 | -0.25 | -0.20 |
Diluted Net EPS (GAAP) | NA | -0.22 | -0.29 | -0.20 | -0.20 |